NCT01296802
- Conditions
- Amphetamine Abuse, Amphetamine-Related Disorders, Chemically-Induced Disorders, +5 more
- Locations
-
- University Hospital of Psychiatry Zurich Zurich, Canton of Zurich, Switzerland
Clinical trial condition
Neurotoxicity Syndromes
Explore clinical trials studying Neurotoxicity Syndromes. Study availability and eligibility vary by location and protocol.
93 public trials
9 recruiting studies
Neurotoxicity Syndromes trial results
NCT00263861
- Conditions
- Chemically-Induced Disorders, Nervous System Diseases, Neurotoxicity, +3 more
- Locations
-
- Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States
Completed
Nerve Changes in Patients Who Are Undergoing Chemotherapy or Biological Therapy for Cancer
NCT00281853
- Conditions
- Chemically-Induced Disorders, Nervous System Diseases, Neurotoxicity, +3 more
- Locations
-
- Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States
NCT00001689
- Conditions
- Acute Lymphocytic Leukemia, Chemically-Induced Disorders, Hematologic Diseases, +13 more
- Locations
-
- National Cancer Institute (NCI) Bethesda, Maryland, United States
NCT00272051
- Conditions
- Chemically-Induced Disorders, Colonic Diseases, Colorectal Carcinoma, +23 more
- Locations
-
Not specified
Active, Not Recruiting
Haloperidol and Lorazepam for Delirium in Patients With Advanced Cancer
NCT01949662
- Conditions
- Advanced Cancers, Chemically-Induced Disorders, Confusion, +15 more
- Locations
-
- University of Texas MD Anderson Cancer Center Houston, Texas, United States
Active, Not Recruiting
To Study the Individual Variants of Chemotherapy-Induced Neurotoxicity
NCT02481336
- Conditions
- Chemically-Induced Disorders, Nervous System Diseases, Neuromuscular Diseases, +3 more
- Locations
-
- National Cheng Kung University Hospital Tainan, Taiwan
Active, Not Recruiting
Neurotoxicity Prophylaxis With Intrathecal Dexamethasone and Simvastatin Post Axi-Cel
NCT04514029
- Conditions
- Chemically-Induced Disorders, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States
Active, Not Recruiting
Anti-CD19 CAR-T Cells With Inducible Caspase 9 Safety Switch for B-cell Lymphoma
NCT03696784
- Conditions
- Chemically-Induced Disorders, Cytokine Release Syndrome, Hemic and Lymphatic Diseases, +17 more
- Locations
-
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States
Active, Not Recruiting
Risk Stratification and Heterogeneity for Organ Damage in Acute Diquat Poisoning
NCT06798142
- Conditions
- Chemically-Induced Disorders, Diquat Poisoning, Nervous System Diseases, +3 more
- Locations
-
- Nanjing Drum Tower Hospital Nanjing, Jiangsu, China